In breast cancer cell line MDA-MB-231, AST-IV inhibited the viability and invasion of tumor cells, downregulated the expression of Vav3, MMP-2, and MMP-9 through suppressing the activation of ERK1/2 and JNK [117]. Here, MMP2 is linked to neoplasm.